1220 related articles for article (PubMed ID: 8752862)
41. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
[TBL] [Abstract][Full Text] [Related]
42. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2002)].
Shimada K; Nakano K; Igari J; Oguri T; Ikemoto H; Mori T; Yokouchi H; Yamamoto M; Inoue H; Nakadate T; Suwabe A; Okada S; Ashino Y; Gejyo F; Okada M; Aoki N; Kitamura N; Suzuki Y; Karasawa Y; Nakata K; Nakatani T; Inagawa H; Kudo K; Kobayashi N; Tanaka T; Kobayashi H; Goto H; Kawai S; Takeda H; Sumitomo M; Matsushima T; Niki Y; Kohno S; Miyazaki Y; Yanagihara K; Hirakata Y; Matsuda J; Nasu M; Hiramatsu K; Suga M; Tosaka M
Jpn J Antibiot; 2004 Jun; 57(3):213-45. PubMed ID: 15376784
[TBL] [Abstract][Full Text] [Related]
43. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2003). III. Secular changes in susceptibility].
Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Hirose T; Sato S; Shigeta S; Fujime M; Fujita K; Yamaguti O; Ishibashi K; Igari J; Suzutani T; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Furuya N; Murai M; Deguchi T; Ishihara S; Ooe H; Matsumoto T; Takahashi K; Nishikawa M; Naito S; Egashira T; Konishi T; Oka T; Kitamura M; Kohno S; Fukuhara Y; Hirakata Y; Kondo A; Matsuda J; Nakano M; Kamidono S; Suzuki Y; Arakawa S; Kumon H; Monden K
Jpn J Antibiot; 2005 Dec; 58(6):557-654. PubMed ID: 16521346
[TBL] [Abstract][Full Text] [Related]
44. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). III Secular changes in susceptibility].
Ogiwara M; Ishibashi K; Yoshida H; Imafuku Y; Murai M; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Watanabe K; Kobayashi Y; Uchida H; Ooe H; Nishikawa M; Matsuda S; Fujime M; Fujita K; Oka T; Takano Y; Miyagawa Y; Furuhama T; Kohno S; Hirakata Y; Mochida C
Jpn J Antibiot; 1999 Mar; 52(3):177-267. PubMed ID: 10367263
[TBL] [Abstract][Full Text] [Related]
45. [Antibacterial activity of oral Cephems against various clinically isolated strains].
Oshiro T; Fukutomi Y; Takayanagi M; Kusaba K; Nagasawa Z; Aoki Y; Nagayama A
Jpn J Antibiot; 2003 Dec; 56(6):681-90. PubMed ID: 15007876
[TBL] [Abstract][Full Text] [Related]
46. [Antibacterial activities of monobactams against fresh clinical isolates].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
[TBL] [Abstract][Full Text] [Related]
47. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1985). III. Secular changes in susceptibility].
Kosakai N; Kumamoto Y; Sakai S; Hirose T; Okayama S; Shigeta S; Shiraiwa Y; Yoshida H; Miura Y; Ogata M
Jpn J Antibiot; 1987 Dec; 40(12):2026-142. PubMed ID: 3448256
[TBL] [Abstract][Full Text] [Related]
48. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1983). I. Susceptibility distribution].
Kosakai N; Igari J; Kumamoto Y; Sakai S; Shigeta S; Shiraiwa Y; Abe K; Tazaki H; Iri H; Uchida H
Jpn J Antibiot; 1985 Aug; 38(8):2185-229. PubMed ID: 4079003
[TBL] [Abstract][Full Text] [Related]
49. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1998)].
Ikemoto H; Arakawa M; Gejyo F; Igarashi K; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Sekine O; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Ohno I; Okada S; Inagawa H; Kudo K; Kobayashi N; Ando M; Suga M; Sato K; Kondo T; Tosaka M; Kobayashi H; Kawai S; Takayasu S; Kohno S; Tomono K; Shimada K; Nakano K; Miyazaki Y; Izumikawa K; Yamaguchi T; Mochida C; Yokouchi H; Ito A; Sumitomo M; Nasu M; Nagai H; Yamasaki T; Matsushima T; Nakano T
Jpn J Antibiot; 2000 May; 53(5):261-98. PubMed ID: 10923284
[TBL] [Abstract][Full Text] [Related]
50. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
Nishino T; Otsuki M; Hatano K; Nishihara Y
Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
[TBL] [Abstract][Full Text] [Related]
51. [In vitro antibacterial activity of various cephems against clinical isolates from complicated urinary tract infections].
Kamidono S; Fujii A; Arakawa S; Kataoka N; Ishigami J
Jpn J Antibiot; 1985 Jan; 38(1):179-89. PubMed ID: 3989977
[TBL] [Abstract][Full Text] [Related]
52. [Antibacterial activities of piperacillin in several fresh clinical isolates].
Matsuzaki K; Koyama H; Omika K; Hasegawa M; Sato Y; Kobayashi I; Kaku M
Jpn J Antibiot; 2000 Aug; 53(8):573-81. PubMed ID: 11070819
[TBL] [Abstract][Full Text] [Related]
53. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2000)].
Shimada K; Terai T; Igari J; Inoue H; Nakadate T; Oguri T; Suwabe A; Obata R; Ikemoto H; Ohno I; Okada S; Hayashi K; Mori T; Nakano K; Arakawa M; Gejyo F; Igarashi K; Yokouchi H; Okada M; Ito A; Sumitomo M; Aoki N; Matsushima T; Niki Y; Kitamura N; Suga M; Suzuki Y; Karasawa Y; Tosaka M; Nakata K; Nakatani T; Kohno S; Tomono K; Miyazaki Y; Inagawa H; Hirakata Y; Aoki S; Matsuda J; Kudo K; Kobayashi N; Kinoshita T; Konosaki H; Nasu M; Nagai H; Kobayashi H; Kawai S; Takayasu S; Hiramatsu K; Nakano T
Jpn J Antibiot; 2002 Oct; 55(5):537-67. PubMed ID: 12532637
[TBL] [Abstract][Full Text] [Related]
54. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
[TBL] [Abstract][Full Text] [Related]
55. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
[TBL] [Abstract][Full Text] [Related]
56. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1983)].
Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Ida S
Jpn J Antibiot; 1985 Nov; 38(11):3119-44. PubMed ID: 3937915
[TBL] [Abstract][Full Text] [Related]
57. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
Ishikawa K; Hamasuna R; Uehara S; Yasuda M; Yamamoto S; Hayami H; Takahashi S; Matsumoto T; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Deguchi T; Matsumoto M; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Wakeda H; Amemoto Y; Onodera S; Goto H; Komeda H; Yamashita M; Takenaka T; Fujimoto Y; Tsugawa M; Takahashi Y; Maeda H; Onishi H; Ishitoya S; Nishimura K; Mitsumori K; Ito T; Togo Y; Nakamura I; Ito N; Kanamaru S; Hirose T; Muranaka T; Yamada D; Ishihara S; Oka H; Inatomi H; Matsui T; Kobuke M; Kunishima Y; Kimura T; Ichikawa T; Kagara I; Matsukawa M; Takahashi K; Mita K; Kato M; Okumura K; Kawanishi H; Hashimura T; Aoyama T; Shigeta M; Koda S; Taguchi K; Matsuda Y
J Infect Chemother; 2015 Sep; 21(9):623-33. PubMed ID: 26166322
[TBL] [Abstract][Full Text] [Related]
58. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). III. Differences in susceptibilities from previous years].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Mochida C
Jpn J Antibiot; 1997 Apr; 50(4):306-410. PubMed ID: 9192248
[TBL] [Abstract][Full Text] [Related]
59. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). III. Secular changes in susceptibility].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Nov; 48(11):1671-756. PubMed ID: 8558756
[TBL] [Abstract][Full Text] [Related]
60. [Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2000--I. Gram-positive bacteria].
Suzuki Y; Nishinari C; Endo H; Tamura C; Jinbo K; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2002 Apr; 55(2):139-53. PubMed ID: 12071093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
